These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12697634)

  • 1. The mechanisms of action of antivirals against hepatitis B virus infection.
    Kamiya N
    J Antimicrob Chemother; 2003 May; 51(5):1085-9. PubMed ID: 12697634
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-abundance drug resistance mutations: extending the HIV paradigm to hepatitis B virus.
    Menzo S; Vincenti D; Solmone M; Prosperi M; Bruselles A; Abbate I; Rozera G; Capobianchi MR
    J Infect Dis; 2009 Dec; 200(11):1798-9; author reply 1799-1800. PubMed ID: 19905934
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel treatment options for hepatitis B virus infection.
    Kumar R; Agrawal B
    Curr Opin Investig Drugs; 2004 Feb; 5(2):171-8. PubMed ID: 15043391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and virological mechanisms of HBV drug resistance.
    Locarnini S; Mason WS
    J Hepatol; 2006 Feb; 44(2):422-31. PubMed ID: 16364492
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment modalities for hepatitis B viral infection and resistance to antiviral therapy.
    Pai SB; Pai RB; Schinazi RF
    Panminerva Med; 2003 Sep; 45(3):165-73. PubMed ID: 14618114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus escape mutants induced by antiviral therapy.
    Sheldon J; Soriano V
    J Antimicrob Chemother; 2008 Apr; 61(4):766-8. PubMed ID: 18218641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro models for studying hepatitis B virus drug resistance.
    Zoulim F
    Semin Liver Dis; 2006 May; 26(2):171-80. PubMed ID: 16673295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing a low-cost drug resistance database for viral hepatitis.
    Kuiken C
    Antivir Ther; 2010; 15(3 Pt B):517-20. PubMed ID: 20516573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variants of hepatitis B virus and their clinical relevance.
    Baumert TF; Barth H; Blum HE
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):95-108. PubMed ID: 15756149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus mutations associated with antiviral therapy.
    Bartholomeusz A; Locarnini S
    J Med Virol; 2006; 78 Suppl 1():S52-5. PubMed ID: 16622878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamivudine-resistant hepatitis B virus and ongoing lamivudine therapy: stop the merry-go-round, it's time to get off!
    Angus P; Locarnini S
    Antivir Ther; 2004 Apr; 9(2):145-8. PubMed ID: 15134176
    [No Abstract]   [Full Text] [Related]  

  • 12. Designing clinical development programs for anti-hepatitis B virus drugs.
    Brown NA
    Methods Mol Med; 2004; 96():499-537. PubMed ID: 14762289
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and virological features of non-breakthrough and severe exacerbation due to lamivudine-resistant hepatitis B virus mutants.
    Suzuki F; Akuta N; Suzuki Y; Sezaki H; Arase Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Ikeda K; Kobayashi M; Matsuda M; Satoh J; Watahiki S; Kumada H
    J Med Virol; 2006 Mar; 78(3):341-52. PubMed ID: 16419116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management.
    Lok AS; Zoulim F; Locarnini S; Bartholomeusz A; Ghany MG; Pawlotsky JM; Liaw YF; Mizokami M; Kuiken C;
    Hepatology; 2007 Jul; 46(1):254-65. PubMed ID: 17596850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The implications of antiviral drugs with activity against hepatitis B virus and HIV.
    Bottecchia M; Garcia-Samaniego J; Soriano V
    Curr Opin Infect Dis; 2007 Dec; 20(6):621-8. PubMed ID: 17975413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus genotypes: an overview.
    Mahtab MA; Rahman S; Khan M; Karim F
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):457-64. PubMed ID: 18842489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus genetic diversity.
    Echevarría JM; Avellón A
    J Med Virol; 2006; 78 Suppl 1():S36-42. PubMed ID: 16622876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of multi-drug resistant hepatitis B virus during sequential therapy.
    Yim HJ; Hussain M; Liu Y; Wong SN; Fung SK; Lok AS
    Hepatology; 2006 Sep; 44(3):703-12. PubMed ID: 16941700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical application of microarray technique to quantify the lamivudine-resistant gene mutant of hepatitis B virus].
    Huang XT; Zeng AP; Lin F
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):185-7. PubMed ID: 17653332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Definitions of resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
    Zoulim F
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S9-11. PubMed ID: 17075488
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.